Colgate-Palmolive (NYSE:CL) Expected to Announce Quarterly Sales of $4.05 Billion
Equities research analysts forecast that Colgate-Palmolive (NYSE:CL) will announce sales of $4.05 billion for the current quarter, according to Zacks. Five analysts have provided estimates for Colgate-Palmolive’s earnings, with the highest sales estimate coming in at $4.08 billion and the lowest estimate coming in at $4.02 billion. Colgate-Palmolive posted sales of $3.88 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 4.4%. The company is expected to issue its next earnings report on Friday, April 24th.
On average, analysts expect that Colgate-Palmolive will report full-year sales of $16.41 billion for the current fiscal year, with estimates ranging from $16.35 billion to $16.53 billion. For the next fiscal year, analysts forecast that the company will post sales of $16.96 billion, with estimates ranging from $16.87 billion to $17.11 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Colgate-Palmolive.
Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.73 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.73. Colgate-Palmolive had a return on equity of 1,906.25% and a net margin of 15.08%. The company had revenue of $4.02 billion during the quarter, compared to the consensus estimate of $3.93 billion. During the same period in the prior year, the company earned $0.74 earnings per share. The company’s revenue for the quarter was up 5.4% compared to the same quarter last year.
Shares of Colgate-Palmolive stock traded down $1.85 during trading hours on Monday, hitting $74.42. The company’s stock had a trading volume of 5,373,653 shares, compared to its average volume of 4,260,187. Colgate-Palmolive has a 12 month low of $64.75 and a 12 month high of $77.41. The stock has a 50 day moving average of $72.83 and a 200 day moving average of $70.52. The company has a market capitalization of $65.37 billion, a PE ratio of 27.06, a price-to-earnings-growth ratio of 5.56 and a beta of 0.70. The company has a debt-to-equity ratio of 43.94, a current ratio of 0.37 and a quick ratio of 0.24.
The business also recently disclosed a quarterly dividend, which was paid on Friday, February 14th. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.43 per share. The ex-dividend date was Wednesday, January 22nd. This represents a $1.72 dividend on an annualized basis and a yield of 2.31%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 60.78%.
In other Colgate-Palmolive news, SVP John J. Huston sold 35,213 shares of the firm’s stock in a transaction on Thursday, February 6th. The stock was sold at an average price of $76.30, for a total value of $2,686,751.90. Following the sale, the senior vice president now owns 84,260 shares of the company’s stock, valued at approximately $6,429,038. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CMO John W. Kooyman sold 21,294 shares of the firm’s stock in a transaction on Thursday, February 6th. The shares were sold at an average price of $76.33, for a total value of $1,625,371.02. Following the completion of the sale, the chief marketing officer now directly owns 17,676 shares in the company, valued at approximately $1,349,209.08. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 220,090 shares of company stock worth $16,418,383. Corporate insiders own 1.14% of the company’s stock.
Several hedge funds have recently modified their holdings of CL. Quest Capital Management Inc. ADV acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $31,000. Horan Capital Advisors LLC. acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $32,000. KCS Wealth Advisory acquired a new stake in shares of Colgate-Palmolive during the 3rd quarter valued at $34,000. Peddock Capital Advisors LLC acquired a new stake in shares of Colgate-Palmolive during the 4th quarter valued at $34,000. Finally, Pacifica Partners Inc. acquired a new position in Colgate-Palmolive during the 4th quarter worth about $36,000. 99.34% of the stock is currently owned by hedge funds and other institutional investors.
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.